Peptides are attracting increased interest as therapeutic agents due to their target specificity, safety, and tolerability. The Fmoc group, a base-labile amine protecting group but stable under acidic conditions, allows for the selective deprotection of the amino acid and subsequent chain elongation. Therefore, Fmoc-protected amino acids are versatile building blocks that are widely used in a variety of solid-phase peptide synthesis (SPPS).